François is a distinguished leader in the pharmaceutical and biotechnology sectors with over 20 years of experience in the discovery and preclinical development of novel therapeutics. He holds a Doctorate in Pharmacy. Before founding ANS Biotech, François held key leadership positions in the R&D divisions of UPSA, Bristol Myers Squibb, and CEREP.
Throughout his career, François has successfully led several R&D projects focused on the characterization of novel chemical matter for the treatment of inflammatory and neuropathic pain. His extensive expertise in this area has led to significant advancements in pain management therapies. François is also a prolific researcher, being the co-author of more than 20 scientific papers.
Today, as the President of ANS Biotech, François continues to drive the company’s mission of supporting analgesic drug discovery. Under his visionary leadership, ANS Biotech has grown to become a prominent player in the biotech industry, known for its innovative approaches and dedication to advancing pharmaceutical research. François’s commitment to excellence and his strategic insight ensure the company remains at the forefront in Pain research and management.